Factors associated with late presentation of HIV infection in Catalonia, Spain

International Journal of STD and AIDS

Volumn 23, Issue 7, 2012, Pages 475-480

  Vives, Nuria ^a,b,c   Carnicer Pont, D ^a,b,c   Garci a de Olalla P ^b,d   Camps, N ^e   Esteve, A ^a,b,c   Casabona, J ^a,b,c  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d Agencia de Salud Publica de Barcelona   (Spain)

^e Agència de Salut Pública de Catalunya a Girona ^*  (Spain)

Author keywords

<350; CD4 cell count; HIV; Late diagnosis; Risk factors; Spain

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; FEMALE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SENESCENCE; SEX DIFFERENCE; SPAIN;

ADULT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DELAYED DIAGNOSIS; FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; POPULATION SURVEILLANCE; RISK FACTORS; SPAIN;

EID: 84864422729     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2011.011280     Document Type: Article

References (27)

1. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006;20:1447-50
2. Fisher M, Pao D, Brown AE, et al. Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach. AIDS 2010;24:1739-47
3. Antiretroviral Therapy Cohort Collaboration. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients. J Acquir Immune Defic Syndr 2007;46:607-15
4. When To Start Consortium, Sterne JA, May M, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009;373:1352-63
5. Jaen A, Esteve A, Miro JM, et al. PISCIS Study Group. Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain). J Acquir Immune Defic Syndr 2008;47:212-20
6. Moreno S, Mocroft A, d'Arminio Montforte A. Medical and societal consequences of late presentation. Antivir Therapy 2010;15(Suppl 1):9-15
7. European Centre for Disease Prevention and Control. Meeting Report: HIV prevention in Europe: Action, needs and challenges. Stockholm, 2-3 October 2006. Stockholm: ECDC, 2006. See http://ecdpc.europa.eu/pdf/MR%20Hiv% 20prevention%20web.pdf (last accessed 01 June 2012)
8. Secretaria del Plan Nacional sobre el Sida. Plan Multisectorial frente a la infeccion por VIH y el sida. Espana 2008-2012. Madrid: Ministerio de Sanidad y Consumo (ES), 2008. See http://www.msps.es/ciudadanos/enfLesiones/ enfTransmisibles/sida/docs/PMS200812.pdf (last accessed 01 June 2012)
9. Johnson M, Sabin C, Girardi E. Definition and epidemiology of late presentation in Europe [review]. Antivir Ther 2010;15(Suppl. 1):3-8
10. Oliva J, Galindo S, Vives N, et al. Delayed diagnosis of HIV infection in Spain. Enferm Infecc Microbiol Clin 2010;28:583-9
11. Antinori A, Coenen T, Costagiola D, et al. Late presentation of HIV infection: a consensus definition. HIV Med 2011;12:61-4
12. Centre d'Estudis Epidemiologics sobre la Sida de Catalunya (CEESCAT). Sistema integrat de vigilancia epidemiologica de l'HIV/sida a Catalunya (SIVES). Informe anual 2000. Barcelona: Generalitat de Catalunya, Departament de Sanitat i Seguretat Social (ES), 2001. Document Tecnic CEESCAT: 13
13. Commission Decision of 28 April 2008 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council (notified under document number C(2008) 1589. 2008/426/EC). See http://eurlex. europa.eu/LexUriServ/LexUriServ.do?url=OJ:L:2008:159:0046:0090:EN:PDF (last accessed 01 June 2012)
14. Ordre SSS/249/2002 d'1 de juliol, per la qua les regulen els fitxers automatitzats que contenen dades de carácter personal en l'ambit del Departament de Salut. Diari Oficial de la Generalitat de Catalunya (ES), no 3678-16/07/2002, p. 1288
15. Instruccio 10/98, d'implantacio de la TSI com a document únic d'identificaciói acreditacio dels usuaris del Servei Catala de la Salut, i del CIP com a codi d'identificació. Servei Cataláde la Salut, 1998
16. Sobrino-Vegas P, García-San Miguel L, Caro-Murillo AM, et al. CoRIS. Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality. Curr HIV Res 2009;7:224-30
17. Girardi E, Aloisi MS, Arici C, et al. Delayed presentation and late testing for HIV: demographic and behavioural risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr 2004;36:951-9
18. Borghi V, Girardi E, Bellelli S, et al. Late presenters in an HIV surveillance system in Italy during the period 1992-2006. J Acquir Immune Defic Syndr 2008;49:282-6
19. Delpierre C, Dray-Spira R, Cuzin L, et al. Correlates of late HIV diagnosis: implications for testing policy. Int J STD AIDS 2007;18:312-17.
20. Klein D, Hurley LB, Merrill D, Quesenberry CP. Review of medical encounters in the five years before a diagnosis of HIV-1 infections: implications for early detection. J Acquir Immune Defic Syndr 2003;32:143-52
21. European Centre for Disease Prevention and Control, WHO Regional Office for Europe. HIV/AIDS Surveillance in Europe 2009. Stockholm: ECDC, 2010. See http://www.ecdc.europa.eu/en/publications/Publications/Forms/ ECDC_DispForm.aspx?ID=590 (last accessed 01 June 2012)
22. European AIDS Clinical Society. Guidelines. Clinical management and treatment of HIV-infected adults in Europe See http://www.europeanaidsclinicalsociety. org/images/stories/EACS-Pdf/EACSGuidelines-v6.0-English.pdf (last accessed 01 June 2012) European AIDS Clinical Society
23. World Health Organization. Scaling up HIV testing and counseling in the WHO European Region-policy framework. Copenhagen: WHO, 2010. See http://www.euro.who.int/_data/assets/pdf_file/0007/85489/E93715.pdf (last accessed June 2012)
24. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health Hum Serv 2011;1-166. See http://www. aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf (last accessed June 2012)
25. Carnicer-Pont D, de Olalla PG, Cayla JA, AIDS Working Group. HIV infection late detection in AIDS patients of an European city with increased immigration since mid 1990s. Curr HIV Res 2009;7:237-43
26. World Health Organization. Guidance on provider-initiated HIV testing and counselling in health facilities. Geneva: WHO, 2007. See http://www.who. int/hiv/pub/vct/pitc2007/en/ (last accessed 01 June 2012)
27. European Centre for Disease Prevention and Control. HIV testing: Increasing uptake and effectiveness in the European Union. Stockholm: ECDC, 2010. See http://www.ecdc.europa.eu/en/publications/Publications/ 101129_TER_HIV_testing_evidence.pdf (last accessed 01 June 2012)